Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-105800
Filing Date
2025-08-08
Accepted
2025-08-08 16:01:03
Documents
109
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q btmd-20250630.htm   iXBRL 10-Q 3917536
2 EX-31.1 btmd-ex31_1.htm EX-31.1 17323
3 EX-31.2 btmd-ex31_2.htm EX-31.2 17697
4 EX-32.1 btmd-ex32_1.htm EX-32.1 10210
5 EX-32.2 btmd-ex32_2.htm EX-32.2 10468
6 GRAPHIC img171502408_0.jpg GRAPHIC 12770
  Complete submission text file 0000950170-25-105800.txt   17283210

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT btmd-20250630.xsd EX-101.SCH 1833092
112 EXTRACTED XBRL INSTANCE DOCUMENT btmd-20250630_htm.xml XML 4080899
Mailing Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038
Business Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038 972-486-9346
biote Corp. (Filer) CIK: 0001819253 (see all company filings)

EIN.: 851791125 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40128 | Film No.: 251198216
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)